Is quantum computing the next big thing? This week, Autonomous Technology and Robotics Director of Research Sam Korus and Associate Portfolio Manager Nick Grous are joined by ARK Chief Futurist Brett Winton to discuss the latest advancements in quantum computing and AI drug discovery. They discuss Google's recent quantum chip announcement, the challenges of scaling quantum technology, and the potential applications in drug discovery. The conversation shifts to the partnership between GlaxoSmithKline and Relation Therapeutics, highlighting the promise of AI in revolutionizing drug development processes, reducing costs, and improving efficiency. The episode concludes with insights on the future of drug development and the potential for significant market changes in the pharmaceutical industry.
If you know ARK, then you probably know about our long-term research projections, like estimating where we will be 5-10 years from now! But just because we are long-term investors, doesn’t mean we don’t have strong views and opinions on breaking news. In fact, we discuss and debate this every day. So now we’re sharing some of these internal discussions with you in our new video series, “The Brainstorm”, a co-production from ARK and Public.com. Tune in every week as we react to the latest in innovation. Here and there we’ll be joined by special guests, but ultimately this is our chance to join the conversation and share ARK’s quick takes on what’s going on in tech today.
Key Points From
|
Keyvan Mohajer, SoundHound AI CEO, joins...
Tom Lee, Fundstrat, and Dan Greenhaus, S...
Richard Jackson, Occidental Petroleum CE...
Fmr. Kansas City Fed Pres. Thomas Hoenig...
The CNBC Business News Update with Peter...
"Rhode has had exceptional performance ....
Are big companies too slow to survive th...
Valvetronic's custom exhausts for Porsch...
What began as outrage over a senior judg...
An American benchmark suggests that hous...
"This is a great moment ... You've got n...
Former San Francisco 49ers sports scient...